Variant report
Variant | esv3514262 |
---|---|
Chromosome Location | chr13:85712822-85713986 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs4576965 | chr13:85712858-85712859 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs544513556 | chr13:85712879-85712880 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs562591612 | chr13:85712880-85712881 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs574783805 | chr13:85712881-85712882 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs541859443 | chr13:85713005-85713006 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs560109329 | chr13:85713009-85713010 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs532125950 | chr13:85713016-85713017 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs555208142 | chr13:85713039-85713040 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs527807694 | chr13:85713041-85713042 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs9575784 | chr13:85713087-85713088 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
11 | rs185572118 | chr13:85713104-85713105 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs531783589 | chr13:85713116-85713117 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs550453677 | chr13:85713141-85713142 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs568747764 | chr13:85713154-85713155 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs368406555 | chr13:85713167-85713168 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs568621176 | chr13:85713234-85713235 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs545758301 | chr13:85713243-85713244 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs137880539 | chr13:85713292-85713293 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs548255990 | chr13:85713349-85713350 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs201508629 | chr13:85713366-85713367 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs199526653 | chr13:85713369-85713370 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs200523763 | chr13:85713370-85713371 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs368198315 | chr13:85713377-85713378 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs142279777 | chr13:85713411-85713412 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs533911628 | chr13:85713435-85713436 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs558338748 | chr13:85713447-85713448 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs146390491 | chr13:85713484-85713485 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs548290359 | chr13:85713511-85713512 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs537601389 | chr13:85713609-85713610 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs139729471 | chr13:85713632-85713633 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs574688019 | chr13:85713640-85713641 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs188895883 | chr13:85713678-85713679 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs553791875 | chr13:85713681-85713682 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs572068216 | chr13:85713698-85713699 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs192383810 | chr13:85713703-85713704 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs564395565 | chr13:85713728-85713729 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs531947862 | chr13:85713732-85713733 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs17079346 | chr13:85713772-85713773 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
39 | rs562284965 | chr13:85713799-85713800 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs9593988 | chr13:85713800-85713801 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
41 | rs548098859 | chr13:85713818-85713819 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs553344586 | chr13:85713826-85713827 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs566480977 | chr13:85713871-85713872 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs527254166 | chr13:85713873-85713874 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Prostate cancer | 16705090 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 22495311 | CNVD |
Chordoma | 21602918 | CNVD |
Bladder cancer | 21949216 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Cancer | 21637783 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 21518781 | CNVD |
colon cancer | 17210682 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Intracranial aneurysm | 19064780 | CNVD |
Breast cancer | 19287154 | CNVD |
Acute myeloid leukemia | 18379011 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Ependymoma | 16718352 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Breast cancer | 16608533 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Breast cancer | 17133270 | CNVD |
Myoepithelioma | 18604193 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Prostate cancer | 18632612 | CNVD |
Colorectal cancer | 21586687 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Developmental delay | 21147756 | CNVD |
Melanoma | 18172304 | CNVD |
Prostate cancer | 16573809 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Non-syndromic sensorineural hearing loss | 18496225 | CNVD |
Breast cancer | 21858162 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Gastric cancer | 17908304 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
abnormal development | 18461090 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18316590 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Prostate cancer | 21965145 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Barrett''s adenocarcinoma | 18663352 | CNVD |
Urothelial cell carcinoma | 18451213 | CNVD |
Developmental delay | 19490664 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Cancer | 21220470 | CNVD |
Cancer | 21183584 | CNVD |
Omodysplasia | 19481194 | CNVD |
Breast cancer | 22032731 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20467480 | CNVD |
Cancer | 17160897 | CNVD |
Mantle cell lymphoma | 19690137 | CNVD |
Rhabdomyosarcoma | 17210683 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr13:85712000-85714000 | Weak transcription | Foreskin Keratinocyte Primary Cells skin02 | Skin |
2 | chr13:85712200-85713800 | Weak transcription | NHEK | skin |
3 | chr13:85712600-85713600 | Weak transcription | HMEC | breast |
4 | chr13:85713600-85714000 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
5 | chr13:85713600-85714000 | Enhancers | Esophagus | oesophagus |
6 | chr13:85713600-85715000 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
7 | chr13:85713600-85715000 | Enhancers | HMEC | breast |
8 | chr13:85713600-85715800 | Enhancers | H1 Cell Line | embryonic stem cell |
9 | chr13:85713600-85715800 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
10 | chr13:85713600-85715800 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
11 | chr13:85713800-85714400 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
12 | chr13:85713800-85714800 | Enhancers | NHEK | skin |
13 | chr13:85713800-85715800 | Enhancers | HUES6 Cell Line | embryonic stem cell |
14 | chr13:85713800-85716200 | Enhancers | HUES48 Cell Line | embryonic stem cell |